[ÕªÒª] Ä¿µÄ ̽ÌÖÊõǰDSA¶ÔÓÚÖ¸µ¼Ö×ÁöÊÖÊõ·½°¸Öƶ¨µÄ¼ÛÖµ£¬ÌرðÊÇÊõǰ¶¯Âö˨Èû¶ÔÓÚÓÐЧµØ¼õÉÙÊõÖгöѪ£¬Ìá¸ßÖ×ÁöµÄÍêÕûÇгýÂÊ£¬Ôö¼ÓÊÖÊõ°²È«ÐÔµÄÒâÒå¡£·½·¨ »Ø¹ËÐÔ·ÖÎö74Àý²»Í¬²¿Î»Ö×ÁöµÄDSA¼ì²éºÍ¶¯Âö˨ÈûµÄ·½·¨ºÍ¼¼ÊõÒòËØ¡£²ÉÓÃSeldinger¡¯s ¼¼Êõ×öÖ×Áö¹©Ñª¶¯ÂöµÄ³¬Ñ¡Ôñ²å¹Ü£¬ÒÔÃ÷½ºº£Ã࣬PVA΢ÇòºÍ½ðÊôµ¯»ÉȦ£¬¶ÔÖ×Áö½øÐÐ˨Èû£¬¶ø¼õÉÙÊõÖгöѪ¡£½á¹û 74ÀýÖ×Áö²¡ÈËÊõǰ½ÓÊÜDSA¼ì²éºÍÊõǰ¶¯Âö˨ÈûÊõ¡£¶¯Âö˨ÈûÊõºó2~5Ìì½ÓÊÜÍâ¿ÆÊÖÊõ¡£ÆäÖÐ71ÀýÊõÖгöѪÃ÷ÏÔ¼õÉÙ£¬68ÀýÖ×Áö²»Í¬³Ì¶ÈËõС£¬63ÀýÖ×ÁöµÃÒÔÍêÕûÇгý¡£½áÂÛ Ö×ÁöÊÖÊõǰDSA ÓÐÖúÓÚ¸üºÃµØÁ˽âÖ×Áö×ÔÉí¼°ÆäÖܱߵÄѪ¹Ü·Ö²¼ºÍ¹©ÑªÇé¿ö£¬ÓÐÀûÓÚÖ¸µ¼ÊÖÊõ¡£Êõǰ¶¯Âö˨Èû¿ÉÃ÷ÏÔʹÖ×ÁöÇгýÊõ³öѪ¸üÉÙ£¬¸ü°²È«£¬Ö×ÁöÍêÕûÇгýÂʸü¸ß£¬ÊÖÊõʱ¼äËõ¶Ì¡£
[¹Ø¼ü´Ê] Ö×Áö£»Íâ¿ÆÊÖÊõ£»Êý×Ö¼õӰѪ¹ÜÔìÓ°£»¶¯Âö˨Èû
Clinical Evaluation of Preoperative Intraarterial Embolization for Tumors ZHANG Yi-jun, TANG Jun, BIAN Hong-yu, HE Jian-jun Department of Radiology, The 1st Affiliated Hospital of Chinese PLA General Hospital, Beijing 100037, China
[Abstract] Objective To evaluate the usefulness of digital subtraction angiography and the effectiveness of preoperative intraarterial embolization for tumors. Methods Seventy-four cases with malignant and benign tumors have accepted preoperative DSA and intraarterial embolization as the assistance for surgical planning and operation procedure. Seldinger¡¯s technique and super selective catherization were employed for all the cases. Gelfoma particle, PVA microsphere and metal coil were used as the emboli. Results All the Seventy-four cases with tumors were well evaluated by preoperative DSA and well planed and designed for the surgical operation. Almost all the surgical operations had been performed successfully with satisfaction on reducing intraoperative bleeding, having a clearer operative field, complete tumor resection, safety and time saving. Conclusion Preoperative DSA is able to do goodness for surgical planning. It can clearly display regional vascular anatomy for surgeons. Preoperative arterial embolization can surely and effectively reduce blood supply to tumors by which surgeons may manage operation more easily with much shorter time.
[Key words] tumor; surgical operation; DSA; embolization
Ö×ÁöÊǵ±½ñΣº¦ÈËÀཡ¿µµÄÖ÷ҪɱÊÖÖ®Ò»£¬¶ø¶ÔÖ×Áö×îΪÀíÏë¶øÓÐЧµÄÖÎÁÆ·½·¨µ±ÊýÍâ¿ÆÊÖÊõ¡£µ±È»£¬Íâ¿ÆÊÖÊõµÄǰÌáÓ¦µ±ÊǾ߱¸Ö×ÁöÇгýµÄÊÊÓ¦Ö¢£¬Ã»ÓÐÔ¶´¦×ªÒÆ¡£ÁíÓÐһЩÖ×Áö£¬ËäÈ»ÊÇÁ¼ÐÔ£¬µ«ÓÉÓÚÆäÄ³Ð©ÌØÐÔ£¬¶Ô»úÌåÓ°Ïì½Ï´ó£¬Ò²ÐèÒªÊÖÊõÇгý¡£È»¶ø£¬Ö×ÁöÊÖÊõ¾³£ÃæÁÙµÄÄÑÌâÊÇ£¬ÊÖÊõÄѶȴó£¬Ö×ÁöѪ¹©·á¸»£¬³öѪ¶à£¬ÍêÕûÇгýÖ×Áö±È½ÏÀ§ÄÑ[1,2]¡£Õë¶ÔÕâÒ»ÄÑÌ⣬ÎÒÃÇÔÚÁÙ´²Êµ¼ùÖУ¬³¢ÊÔ¶Ô²¿·ÖÖ×Áö²¡È˽øÐÐÊõǰѪ¹ÜÔìÓ°¶ÔÖ×ÁöѪ¹Ü½øÐÐÆÀ¹À£¬²¢ÔÚÊÖÊõǰ¶ÔÖ×ÁöµÄÏà¹Ø¹©Ñª¶¯Âö(supplying artery)½øÐÐ˨Èû£¬¶Ô½â¾öÉÏÊöÄÑÌ⣬ÌṩÁ˼«´óµÄ°ïÖú£¬²¢¹ãÊÜÍâ¿ÆÒ½Éú»¶Ó¡£ÎªÈ·±£Ñª¹ÜÔìÓ°¼ì²éµÄÈ«ÃæºÍ׼ȷ£¬ÎÒÃDzÉÓõÄÊÇÊý×Ö¼õӰѪ¹ÜÔìÓ°£¨digital subtraction angiography, DSA£©£¬¼¼ÊõºÍÉ豸¡£
±¾ÎĶÔÒ»×é1997ÄêÖÁ2006Äê¼ä£¬½ÓÊÜÊõǰ˨ÈûµÄ74ÀýÖ×Áö²¡È˽øÐÐÁ˻عËÐÔ·ÖÎöºÍÏà¹Ø¼¼Êõ̽ÌÖ£¬ÏÖ±¨¸æÈçÏ£º
²ÄÁϺͷ½·¨
1¡¢ÁÙ´²×ÊÁÏ
±¾×é¹²74ÀýÖ×Áö²¡ÈË£¬ÄÐ52Àý£¬Å®19Àý¡£ÄêÁä28Ëê~73Ë꣬ƽ¾ù54.2Ëê¡£ÆäÖжñÐÔÖ×Áö59Àý£¬Á¼ÐÔÖ×Áö12Àý¡£Ö×ÁöµÄ²¿Î»ºÍÖÖÀà°üÀ¨£ºÄÔÖ×Áö£¬ÄÔĤÁö£¬ò¢Ã沿ºÍÍβ¿Ñª¹ÜÁö£¬±ÇÑʲ¿ÏËάѪ¹ÜÁö£¬·Î°©£¬¸Î°©£¬Éö°©£¬×Ó¹¬¼¡Áö£¬¹¬¾±°©£¬ÒõµÀ°©£¬Ö±³¦°©¡¢÷ĹÇÖ×Áö£¬÷¾¹ÇÖ×Áö£¬ËÄÖ«¹ÇÈâÁö¡£ËùÓв¡È˾ùÔÚÊõǰ½ÓÊܹý³¬Éù¡¢CTºÍMRI¼ì²é£¬Ö×ÁöµÄÕï¶ÏÓÉÉÏÊö¼ì²éºÍʵÑéÊÒ¼ì²éÈ·Á¢¡£²¿·Ö²¡ÈËÔø½ÓÊÜÄÚ¿ú¾µ¼ì²éºÍ³¬Éù»òCTÒýµ¼Ï´©´Ì»î¼ì¡£
2¡¢É豸¼°²ÄÁÏ£º
DSAÉ豸ΪÃÀ¹úGE¹«Ë¾1000mA ¡°C¡±ÐͱÛAdvantx LCV+ DSAϵͳ¡£½éÈëÓõ¼¹Ü²ÉÓÃÃÀ¹úCOOK¹«Ë¾Éú²úµÄ4F£¬5F²»Í¬¹æ¸ñºÍÐͺŵĵ¼¹Ü£¬³£Óõ¼¹ÜÀàÐͰüÀ¨£ºCobra, Simmons, HeadhunterºÍTerumoͬÖá΢µ¼¹ÜSPµ¼¹Ü¡£Ë¨Èû¼ÁΪֱ¾¶250~750΢Ã×µÄPVA£¨Polyvinyl Alcohol£©Î¢ÇòºÍÃ÷½ºº£Ãà¿ÅÁ£¡¢µâ»¯ÓÍ(lipiodol)£¬²¿·Ö²¡ÀýÑ¡ÓýðÊôµ¯»ÉȦ¡£
3¡¢·½·¨Óë²½Ö裺
²ÉÓÃSeldinger¡¯s·¨Ðйɶ¯Âö´©´Ì²å¹Ü£¬ÖÃÈë4F»ò5FÔìÓ°µ¼¹Ü£¬ÏÈÐÐÖ×ÁöÇøÓòÏà¹Ø¶¯ÂöµÄDSA¼ì²é¡£¶øºóÒÀÿÀýÖ×ÁöµÄ¾ßÌ岿λ¡¢ÖÖÀàºÍÆäËûÌØµã£¬¶øÐÐÑ¡ÔñÐÔ»ò³¬Ñ¡ÔñÐÔ¶¯Âö²å¹Ü£¬Ê¹µ¼¹Ü¾¡¿ÉÄܽӽüÖ×ÁöËùÔÚ²¿Î»£¬ÔÙÐÐDSA¼ì²é֤ʵ£¬ËæºóÔÚDSAµçÊÓÑϸñ¼àÊÓÏ£¬¾µ¼¹Ü»ºÂý×¢ÈëÃ÷½ºº£Ãà΢Á£»òPVA΢Çò¡£¶Ô½Ï´Ö´óµÄÖ×Áö¹©Ñª¶¯Âö£¬¿É¼ÓÓýðÊôµ¯»ÉȦ½øÐÐ˨Èû¡£µ±ÆÕͨµ¼¹ÜÎÞ·¨½Ó½üÖ×Áöʱ£¬Ó¦Ñ¡ÓÃSP΢µ¼¹Ü£¬Í¨³£¿ÉʵÏÖ½ÏΪÀíÏëµÄ¶¯Âö˨Èû¡£
¶¯Âö˨ÈûÍê³Éºó£¬Ó¦×¢Òâ·¢ÏÖÓÐÎÞÆäËüµÄ²àÖ§¹©Ñª£¬Ò»µ©·¢ÏÖ£¬Ó¦Ò»²¢½øÐÐ˨Èû¡£·ñÔò£¬½«ÎÞ·¨´ïµ½Ô¤ÆÚµÄÍâ¿ÆÊÖÊõÄ¿µÄ¡£ÓÐÐí¶àλÓÚÖÐÏß»ò½Ó½üÖÐÏßµÄÖ×Áö£¬Í¨³£ÊÇÓÐË«²àѪҺ¹©Ó¦£¬±ÈÈ磺²¿·ÖÄÔĤÁö£¬Ã沿Ѫ¹ÜÁö£¬÷¾¹ÇÖ×Áö£¬×Ó¹¬µÄÁ¼¶ñÐÔÖ×ÁöµÈ¡£¶ÔÓÚ¶ñÐÔÖ×Áö²¡ÈË£¬Ò²¿ÉÔÚ˨Èûǰ×ö»¯ÁÆÒ©Îï¹à×¢£¬ÒÔ¼ÓÇ¿¶ÔÖ×ÁöµÄÒÖÖÆ×÷Óá£
½á¹û
1¡¢DSA±íÏÖ£º
±¾×é74ÀýµÄDSA±íÏÖ£¬»ù±¾º¸ÇÁ˸÷ÖÖÖ×ÁöµÄѪ¹ÜÓ°ÏñÑ§ÌØµã¡£¾ø´ó¶àÊý¶ñÐÔÖ×ÁöµÄѪҺ¹©Ó¦½ÏÕý³£Ôö¶à£¬¾ßÌå±íÏÖΪ£º¹©Ñª¶¯ÂöÔö´Ö£¨57Àý£©£¬ÑªÁ÷Á¿Ôö´ó£¨64Àý£©£¬Ö×ÁöѪ¹ÜÔöÉú£¨68Àý£©£¬Ñª¹ÜÊýÁ¿Ôö¶à£¨hyppervascularity£©£¨67Àý£©£¬ÐÎ̬ÎÉÂÒ£¨70Àý£©£¬Ñª¹ÜÊÜÍÆÒÆ£¬ÒÆÎ»£¨44Àý£©£¬¿É³Ê¡°±§Çò×´¡±¸Ä±ä£¨16Àý£©£¬ÒÔ¼°Ö×ÁöȾɫ£¨tumor stain£©£¨65Àý£©ºÍѪ¹Ü°üÈÆÕ÷£¨vascular encasement£©£¨8Àý£©¡£²¿·Ö²¡ÀýÓж¯¾²Âö¶Ì·£¨arterio-venous shunt£©£¬¾²ÂöÌáǰÏÔÓ°£¨19Àý£©¡£
2¡¢¶¯Âö˨Èû£º
74Àý²¡È˾ùʵÏÖÁ˽ÏΪÀíÏëµÄ¶¯Âö˨Èû¡£ÆäÖУ¬49ÀýÑ¡ÓÃÁË΢µ¼¹Ü³¬Ñ¡Ôñ¶¯Âö˨Èû£¬22ÀýÓÃ4F¡¢5Fµ¼¹Ü½øÐÐ˨Èû¡£Òò¿¼Âǵ½²¡È˽«»áºÜ¿ì½ÓÊÜÍâ¿ÆÊÖÊõ£¬ËùÒÔ£¬¶Ô¶àÊý²¡È˲ÉÓÃÁËÖ±¾¶500~750΢Ã×µÄÃ÷½ºº£Ãà΢Á££¬»ò1¡Á1¡Á1ºÁÃ×µÄÃ÷½ºº£Ãà¿ÅÁ£½øÐÐ˨Èû¡£¶Ô22Àý²¡ÈËʹÓÃPVA΢Çò×÷Ϊ˨Èû¼Á£»¶Ô21ÀýʹÓÃÁ˵⻯ÓÍ£¨»òÁí¼ÓPVA΢Çò£©×ö˨Èû£»ÁíÓÐ13ÀýʹÓÃÁ˽ðÊôµ¯»ÉȦ¡£
3¡¢¶¯Âö˨ÈûÓëÍâ¿ÆÊÖÊõʱ¼ä¼ä¸ô£º
ÒÀ¾ÝÖ×ÁöµÄÖÖÀà¡¢´óС¡¢Á¼¶ñÐÔ¡¢²¿Î»²»Í¬£¬½áºÏÍâ¿ÆÒ½ÉúµÄÐèÇ󣬱¾×é74Àý¶¯Âö˨ÈûºóʵʩÍâ¿ÆÊÖÊõµÄ¼ä¸ôʱ¼äÔÚ2~5Ìì¡£
4¡¢Íâ¿ÆÊÖÊõʱ¼äºÍÊõÖгöѪÁ¿£º
ÊõÖмû¹©ÑªÖ×Áö¾Ö²¿¼°ÁÚ½üµÄ¶¯Âö·ÖÖ§²«¶¯Ã÷ÏÔ¼õÈõ£¬ÉõÖÁÏûʧ£¬²¿·Ö²¡Àý¿É¼û¶¯ÂöÄÚÓÐѪ˨Ðγɣ¬Ö×Áö±íÃæ¾²ÂöήÏÝ£¬Ö×ÁöÓëÕý³£×éÖ¯Ò×·ÖÀë¡£ÊõÖгöѪÁ¿Ã÷ÏÔ¼õÉÙ£¬Æ½¾ùÊÖÊõʱ¼ä¿ÉËõ¶Ì1/4~1/3¡£
ÓÐ3ÀýÔÚÍâ¿ÆÊÖÊõÖгöѪ¿ØÖÆÇ·ÂúÒ⣬·ÖÎöÆäÔÒò£¬ÎªÊõǰ¶¯Âö˨Èûʱ£¬½ÏÄêÇáµÄ½éÈëÊÖÊõҽʦ¶ÔÆäËü²à֧Ѫ¹Üδ¼°Ê±·¢Ïֺʹ¦Àí²»ÍêÉÆËùÖ¡£ËùÓнéÈëÐÔ¶¯Âö˨Èûδ·¢ÉúÑÏÖØ²¢·¢Ö¢¡£
ÌÖÂÛ
Ö×ÁöµÄÍâ¿ÆÊÖÊõÇгýÊÇÖ×ÁöÖÎÁÆÖÐ×îΪÀíÏëºÍ×îΪÓÐЧµÄ·½·¨¡£µ«ÈçºÎ¼õÉÙÊÖÊõÖгöѪ£¬ÈçºÎʹÊÖÊõÖÐÖ×Áö±©Â¶µÄ×îÇå³þ£¬×î³ä·Ö£¬ÈçºÎÄܽ«Ö×Áö×îÍêÕûµØÇгý£¬Í¬Ê±£¬×î´óÏ޶ȵؼõÉÙ¶ÔÁÚ½üÖØÒªÆ÷¹ÙºÍ×éÖ¯µÄËðÉË£¬ÊÇÍâ¿ÆÒ½Éú¼«Îª¹Ø×¢£¬Ò²ÊÇ×îÏ£Íû½â¾öµÄ¡£
1¡¢ ÊõǰDSAµÄÒâÒ壺
ÊõǰDSAÎÞÂÛ¶Ô½éÈëÒ½ÉúºÍÍâ¿ÆÒ½Éú£¬¶¼¾ßÓÐÊ®·ÖÖØÒªµÄÒâÒå¡£ÊõǰDSA¿ÉÒÔÖ¸µ¼½éÈëÒ½Éú׼ȷ¡¢È«Ãæ¡¢ÍêÉÆµØ½øÐж¯Âö˨Èû£¬ÓÐЧµØ±ÜÃâ¶ÔÓÚ¶à¸ö²àÖ§¹©ÑªÑª¹Ü·¢Éú¡°Â©Ë¨¡±¶øÓ°ÏìÍâ¿ÆÊÖÊõЧ¹û¡£
׼ȷµØ·¢ÏÖºÍÅж¨Ö×ÁöµÄ¹©Ñª¶¯Âö£¬ÓÈÆäÊÇ׼ȷµØ·¢ÏÖÓпÉÄÜ´æÔڵĵڶþÖ§µÚÈýÖ§¹©Ñª¶¯Âö£¬ÓÐÀûÓÚÖ¸µ¼½éÈëÊÖÊõÒ½ÉúµÄ˨ÈûÊÖÊõ¡£Í¬Ê±Ò²ÓÐÀûÓÚÍâ¿ÆÒ½Éú³ä·ÖÁ˽âÖ×Áö¾Ö²¿ºÍÖÜΧµÄѪ¹Ü·Ö²¼Çé¿ö£¬ÓÈÆäÊÇÖ×ÁöµÄ¹©Ñª¶¯ÂöÇé¿ö£¬²¢½øÐнÏΪÀíÏëµÄÍâ¿ÆÊÖÊõ¼Æ»®µÄÖÆ¶¨(surgical planning) [3]¡£ÓÐÖúÓÚÇ¡µ±µØÑ¡ÔñºÃÊÖÊõÈë·¡¢ÊÖÊõ·¶Î§¡¢Ö×ÁöµÄ¹ã¶ÈºÍÉî¶È£¬ÄÄЩѪ¹Ü·ÖÖ§Òѱ»Ë¨Èû£¬ÄÄЩδ×ö˨Èû£¬¶øÐèÒªÔÚÊõÖм°Ê±½áÔú»ò¼Ð±Õ¡£ËüÄÜʹÍâ¿ÆÒ½ÉúÔÚÊõǰ¸ü¼ÓÐÄÖÐÓÐÊý£¬´Ó¶øÊ¹µÃÊÖÊõ¸ü¼Ó°²È«¿ì½Ý¡£Òò´Ë£¬ÊõǰµÄѪ¹ÜÔìÓ°ÊǷdz£±ØÒªµÄ[1,2]¡£
±ÊÕßÈÏΪ£º¶ÔÓÐÌõ¼þÕߣ¬¶¯Âö˨ÈûǰµÄCTѪ¹ÜÔìÓ°£¨computed tomography angiography, CTA£©½«ÓÐÖúÓÚ¸ü¼ÓÈ«ÃæµØÁ˽âÖ×Áö±¾Éí¡£ÌØ±ðÊÇCTAµÄ3D³ÉÏñ£¬¿ÉÁ¢Ì嵨¡¢¶à½Ç¶ÈµØ¡¢Çå³þµØÏÔʾÖ×ÁöµÄÖÜΧ½âÆÊ½á¹¹£¬ÓÈÆäÊÇÖ×ÁöµÄ¹©Ñª¶¯ÂöµÄÀ´Ô´ºÍ·Ö²¼Çé¿ö¡£CTAÓëDSA²¢·ÇÖØ¸´£¬Ç°Õ߼ȿÉÒÔÆÀ¼ÛÖ×Áö£¬ÓÖ¿ÉÁ˽âѪ¹ÜÇé¿ö£»¶øDSAÊǶ¯Âö˨ÈûǰËù±ØÐëµÄ²½Ö裬CTA¶ÔDSA¼°¶¯Âö˨ÈûÒ²ÓнϴóµÄÖ¸µ¼×÷Óá£Í¬Ê±ÎÒÃǼá³ÖÈÏΪ£ºË¨ÈûǰµÄѪ¹ÜÔìÓ°Ó¦±ÜÃâ²ÉÓÃÆÕͨѪ¹ÜÔìÓ°£¬¶øÓ¦Ñ¡ÔñDSA¡£ÒòΪֻÓÐDSA¿ÉÒÔ¼õ³ý¹Ç÷À¡¢Æ÷¹ÙºÍ×éÖ¯µÈÓëѪ¹ÜÎÞ¹ØµÄ½á¹¹ÖØµþÓ°£¬¶ø¸ü¼ÓÇå³þ¶øÈ«ÃæµØÏÔʾѪ¹ÜµÄÐÎ̬¡¢·Ö²¼¡¢´Öϸ¡¢¶¯¾²ÂöÒì³£½»Í¨µÄÓÐÎÞ¡¢ÓÈÆäÊÇѪ¹ÜÓëÖ×ÁöµÄ¹ØÏµ¡£¼°Ê±¶ø×¼È·µØ·¢ÏÖ¶¯¾²ÂöÒì³£½»Í¨Ö¹ØÖØÒª£¬ËüÖ±½Ó¹ØÏµµ½±ÜÃâ˨×Ó½øÈë·Ç°ÐÆ÷¹Ù¡¢°Ð×éÖ¯£¬ÉõÖÁ½øÈëÌåÑ»·¶øÒýÆðÎó˨£¬¼°Æä¿ÉÄÜÓÉ´ËÒýÆðµÄÑÏÖØ²¢·¢Ö¢¡£
2¡¢ Êõǰ¶¯Âö˨ÈûµÄÒâÒ壺
ÎÒÃÇÖªµÀ£¬³£¹æµÄÖ×ÁöÊÖÊõͨ³£»áÃæÁÙ£ºÖ×ÁöѪÔ˷ḻ£¬ÁÚ½ü½âÆÊ½á¹¹¸´ÔÓ£¬³öѪ¶à£¬ÊÖÊõÒ°²»Çå³þ£¬ÈÝÒ×ËðÉËÁÙ½üÕý³£×éÖ¯£¬ÇÒ²»ÀûÓÚÖ×ÁöµÄÍêÕûÇгý£¬µÈÎÊÌâ¡£¶øÊõǰ¶¯Âö˨ÈûµÄÖ÷Ö¼ÕýÊÇΪÁ˽â¾öÕâЩÄÑÌ⣬¶øÓÐÄ¿µÄµØÌṩ·Ç³£ÓÐЧµÄ°ïÖú¡£
Óб¨µÀÈÏΪ£¬ÄÔĤÁö¡¢±ÇÑʲ¿ÏËάѪ¹ÜÁöµÈ¸ßѪÔËÖ×Áö£¬ÈôÖ±½ÓÊÖÊõÇгý£¬½«ÃæÁÙÊõÖгöѪ¶à£¬ÉõÖÁ³öÏÖÐݿ˺ÍΣ¼°ÉúÃü[4]¡£Í¬Ê±Ò²¿ÉÒò´ó³öѪ¶øÖ±½ÓÓ°ÏìÖ×ÁöµÄÈ«ÇУ¬ÆäÊõºóÖ×Áö¸´·¢ÂÊΪ25-60%[5]¡£¶¯Âö˨ÈûÒ»·½ÃæÊÇΪÍâ¿ÆÊÖÊõÌṩ·½±ã£¬ÁíÒ»·½Ã棬Æä±¾ÉíÒ²ÒѳÉΪÖ×Áö¸¨ÖúÐÔÖÎÁƼ°¹ÃÏ¢ÖÎÁƵÄÓÐЧÊÖ¶Î[6]¡£ÓÐ×÷Õß¶ÔÍâ¿ÆÊÖÊõǰ¶¯Âö˨ÈûÓë·ñµÄÊõÖгöѪÁ¿×ö¹ýÈÏÕæµÄ±È½Ï¡£ÆäÖÐMatsumaru Y£¬µÈÈÏΪ£¬ÒÔÄÔÖ×ÁöΪÀý£¬Î´×ö¶¯Âö˨ÈûÕߣ¬ÊõÖÐÆ½¾ù³öѪ1000-2000ºÁÉý£¬¶ø½ÓÊܶ¯Âö˨ÈûÕߣ¬Æ½¾ù³öѪΪ150-500ºÁÉý[1]¡£Ò²ÓÐÎÄÏ×±¨µÀ£¬±ÇÑʲ¿ÏËάѪ¹ÜÁöÊÖÊõʱ³öѪÐ×ÃÍ£¬³öѪÁ¿¿É¶à´ï2500-3000ºÁÉý[7]¡£
¸ù¾ÝÎÒÃǵÄÁÙ´²Êµ¼ù£¬ÎÒÃÇÈÏΪ£º·²Ã»ÓÐÃ÷ÏÔ˨Èû½û¼É£¬¶øÓÖ×¼±¸½øÐÐÊÖÊõÖÎÁƵIJ¡ÈË£¬¾ùÓ¦»ý¼«¿¼ÂÇʵʩÍâ¿ÆÊÖÊõǰ¶¯Âö˨Èû¡£ÔÚÓöÓÐÏÂÁÐÇé¿öʱ£¬ÓÈÆäÓ¦»ý¼«ÊµÊ©¶¯Âö˨Èû£ºÖ×Áö·¢ÉúÔÚÌØÊâµÄ½âÆÊλÖã¬Ö×ÁöλÖÃÉÊõÖв»Ò×ÏÔ¶£¬Ñª¹©·á¸»£¬ÊõÖгöѪÁ¿½Ï¶à£¬ÊÖÊõÊÓÒ°²»Ç壬ÓëÖÜΧ×éÖ¯ÑÏÖØÕ³Á¬[8]¡£
3¡¢¶¯Âö˨ÈûµÄ×¢ÒâÊÂÏ
3.1Õû¸ö¶¯Âö˨Èû¹ý³Ì±ØÐëÔÚÑϸñµÄµçÊÓ¼àÊÓϽøÐУ¬×¢Éä˨Èû¼Áʱ±ØÐ뻺Âý£¬ÕâÓÐÀûÓÚ±ÜÃâÎó˨ºÍÆäËû²¢·¢Ö¢µÄ·¢Éú£»DSAѪ¹Ü·ͼ¼¼Êõ(road mapping)ÓÐÖúÓÚÌá¸ß³¬Ñ¡Ôñ²å¹ÜµÄ³É¹¦ÂÊ¡£
3.2Ôڼƻ®ºÃÍâ¿ÆÊÖÊõʱ¼äµÄÇé¿öÏ£¬Í¨³£Ñ¡ÓÃÁÙʱ˨Èû¼Á¼´¿É£¬¼Û¸ñÒ²½ÏµÍÁ®¡£Ò»°ãÈÏΪ£¬Ã÷½ºº£Ãà˨Èûºó7-21Ìì˨ÈûµÄѪ¹Ü¿ÉÄÜÔÙͨ¡£¹ÊÍâ¿ÆÊÖÊõÓ¦ÔÚÒ»ÖÜÄÚ½øÐÐ[8]£»
3.3˨Èû¹ý³ÌÖÐÎñ±ØÒª×¢Òâ·¢ÏÖ¶àÖ§¹©Ñª¶¯Âö£¬²¢·Ö±ð¶ÔÆä½øÐÐ˨Èû£»
3.4Ӧע֨¶ÔѪ¹Ü´²µÄ˨Èû£¬¶ø·Ç½ö½ö¶ÔѪ¹ÜÖ÷¸ÉµÄ˨Èû£¬·ñÔòÎÞ·¨È·±£ÓÐЧµØ¼õÉÙ³öѪ£»
3.5˨ÈûÓ¦ÓÐ˳ÐòµØ½øÐУ¬ÇмDZÜÃâ¹ýÔçµØË¨Èû¹©Ñª¶¯ÂöÖ÷¸É[2]£¬¶øÓ¦ÓÉÔ¶¼°½üµØÊµÊ©£»
3.6µ±Ö÷Òª¹©Ñª¶¯Âö˨ÈûÍê³Éºó£¬±ØÐë½øÐÐDSA¸´²é£¬Ò»·½ÃæÔÚÓÚÈ·ÈÏ˨ÈûЧ¹û¡£ÁíÒ»·½ÃæÔÚÓڲ鿴ÆäËü²à֧Ѫ¹ÜµÄÓÐÎÞ£¬±ÜÃâÒÅ©¡£×î¼Ñ¶¯Âö˨Èûʱ¼äºÍÊÖÊõʱ¼äÎÒÃÇÈÏΪӦÔÚ˨ÈûºóµÚ2~5ÌìΪÒË¡£
4»Ø¹ËÐÔ·ÖÎö±¾×é74ÀýÊõǰ¶¯Âö˨Èû²¡Àý£¬ÎÒÃÇÈÏΪ
4.1¶¯Âö˨Èû¿ÉÓÐЧµØ¼õÉÙÊõÖгöѪ[2]£¬Ê¹ÊÖÊõÒ°¸üÇå³þ£¬Ö×Áö¸üÒ×ÓÚ±©Â¶£¬Ê¹ÁÚ½üµÄ½âÆÊ½á¹¹¸üÈÝÒ×ÏÔ¶£¬¶ø×î´óÏ޶ȵرÜÃâÊõÖÐÎóÉË£¬½µµÍÁËÊÖÊõµÄäĿÐÔºÍΣÏÕÐÔ£¬ÎªË³Àû¡¢³¹µ×ÇгýÖ×Áö´´ÔìÁËÌõ¼þ¡£´Ó¶øÒ²½µµÍÁËÊõºóµÄ¸´·¢ÂÊ¡£¶¯Âö˨Èû¿ÉÒÔ¼«´óµØËõ¶ÌÊÖÊõʱ¼ä[9]£¬ÕâÒâζ×ÅËõ¶ÌÁËÊÖÊõÇøÓòÖÐÆ÷¹ÙºÍ×éÖ¯±©Â¶µÄʱ¼ä£¬¸üÓÐÀûÓÚ²¡ÈËÊõºóµÄ»Ö¸´£¬Õâµã¶ÔÓÚ¿ªÂÊÖÊõÓÈÎªÖØÒª[4]¡£
4.2¼õÉÙÊõÖгöѪ±ãÒâζ×Ų¡ÈËʧѪ¼õÉÙ£¬ÕâÎÞÒÉ»á¸üÓÐÀûÓÚ²¡ÈËÊõºóµÄ»Ö¸´¡£Í¬Ê±£¬Ò²¿É¼õÉÙ²¡È˶îÍâÊäѪµÄ·ÑÓúÍÓëÊäѪÓйصķçÏÕ£»
4.3¶¯Âö˨Èû¿ÉÒÔʹÖ×ÁöÌå»ýËõС¡¢ÖÐÐÄ»µËÀ¡¢Èí»¯ÉõÖÁ·¢Éú²¿·ÖÒº»¯¡£ÓÉ´ËʹµÃ£ºÖ×ÁöÇгý¸üÈÝÒ×£»¿ÉÒÔ×î´óÏ޶ȵر£ÁôÕý³£×éÖ¯£»¼õСÊÖÊõÇпڣ¬¾¡¿ÉÄÜСµØÓ°Ï첡È˵ÄÊÖÊõÇøµÄÍâ¹Û£»
4.4ʹÖ×Áö½çÏÞÇå³þ£¬ÕâÑùÍâ¿ÆÒ½Éú¾Í¸üÈÝÒ׽綨Ö×Áö×éÖ¯ÓëÕý³£×éÖ¯£¬¿ÉÒÔ¸ü¸É¾»¡¢ÍêÕûµØÇгýÖ×Áö×éÖ¯£¬´Ó¶øÒ²½µµÍÁËÊõºóµÄ¸´·¢ÂÊ£»Ò²¿É¸ü¶àµØ±£ÁôÕý³£µÄ×éÖ¯ºÍÆ÷¹Ù£»
4.5¶¯Âö˨Èû±¾Éí¶ÔÖ×Áö¾ßÓÐÒÖÖÆ×÷Óã¬ÓÐÖúÓÚ·ÀÖ¹Ö×ÁöµÄÀ©É¢¡£
×ÛÉÏËùÊö£¬Êõǰ¶¯Âö˨ÈûÎÞÂÛ¶Ô¼õÉÙÊÖÊõ³öѪ£¬Ëõ¶ÌÊÖÊõʱ¼ä£¬¾¡¿ÉÄÜÍêÕûµØÇгýÖ×ÁöºÍ¼õÉÙÖ×Áö¸´·¢£¬¶¼Óм«´óµÄ°ïÖú£¬ÖµµÃÁÙ´²Ò½Éú»ý¼«Ñ¡Óá£
²Î¿¼ÎÄÏ×£º
1 Matsumaru Y, Hyodo A, Nose T, et al. Embolic materials for endovascular treatment of cerebral lesions[J]. J Biomater Sci Polym, 1997,8(7):555-569.
2 Waknloo A, Juengling F, Van-Velthoven, et al. Extended preoperative polyvinyl zlcohol microembolization of intracranial meningiomas: assessment of two E techniques[J]. AJNR, 1993,14(3):571-582.
3 ÂÀºéÕ£¬ËåÓêУ¬ÕÅÁáÁᣬµÈ.Ñ¡Ôñ±ÇÑʲ¿ÏËάѪ¹ÜÁö¹©ÑªAÊõǰ˨ÈûµÄÁÙ´²Ó¦ÓÃ[J].ÄÚÃɹÅҽѧÔÓÖ¾£¬2006, 38(6): 496-498.
4 Bendszus M, Warmuth-Metz M, Klein R, et al. Sequential MRI and MR spectoscopy in embolized meningiomas: correlation with surgical and histopathological findings[J]. Neuroradiology, 2002, 44(1):77-82.
5 Lasjavnias P, Picard L, Manelfe C, et al. Angiogfibroma of the nasopharyn[J]. J neurordiol, 1980, 7:73.
6 Salai M, Garniek Ak, Rubstein I, et al. Preoperative angiography and E of large pelvic tumors[J]. J Surg Oncol, 1999,70(1):41-43.
7 κÓñ÷£¬ÍõÌìîì.±ÇÑʲ¿ÏËάѪ¹ÜÁöÖÎÁÆÏÖ×´[J]. ¹úÍâҽѧ¶ú±Çºí¿ÆÑ§·Ö²á, 2004,28(2):109-110.
8 ÀîÊØÇ¿£¬Ðì΢³¾£¬ÀîÃÃ,µÈ.Êõǰ¶¯Âö˨ÈûÔÚ÷¾¹ÇÖ×ÁöÖÎÁÆÖеļÛÖµ[J].Öйú½ÃÐÎÍâ¿ÆÔÓÖ¾£¬2004,12£¨13£©:977~979.
9 Àî¹ð½Ü£¬ÕÅÀöƼ£¬Ëï½à.Éö¼°ÉöÉÏÏÙ¶ñÐÔÖ×ÁöÊõǰ¶¯Âö˨ÈûµÄÁÙ´²ÒâÒå[J].ɽ¶«Ò½Ò©£¬2004£¬44£¨5£©£º62~63.

TAG: ¶¯Âö˨Èû Íâ¿ÆÊÖÊõ Ö×Áö





